(Q50675471)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Erica M. Wood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Helen Ingham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Anthony J Keller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Australian Red Cross Blood Service Donor and Product Safety Team

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

24 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

55-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17894794%20AND%20SRC:MED&resulttype=core&format=json

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Transfusion-associated transmission of West Nile virus, United States 2003 through 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Effects of oral donor questioning about high-risk behaviors for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

History of previous drug misuse in HCV-positive blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. The HIV Blood Donor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Screening potential blood donors at risk for human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Interviews of individuals diagnosed as anti-human immunodeficiency virus-positive through the screening of blood donations in the Paris area to 1994: reflections on the selection of blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Behavioural risk factors for HIV infection amongst blood donors in London.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Estimates of chronic hepatitis B virus infection in Australia, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Do blood donors read and understand screening educational materials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Risk-behavior reporting by blood donors with an automated telephone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Safety of the blood supply in the United States: opportunities and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

Nucleic acid amplification technology methods used in blood donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X

The need for continuing vigilance: addressing the threat for transmission of blood-borne infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01482.X